Alluvi tirzepatide has been emerged as a promising therapeutic agent for the treatment of metabolic disorders. This initial evaluation investigated the efficacy and profile of tirzepatide 40mg in animal models of insulin resistance. The studies demonstrated that tirzepatide 40mg significantly elevated glycemic control and reduced insulin levels. Mo